Oct 16 (Reuters) - Swiss drugmaker Roche Holding AG said there was "no change" to its merger and acquisition strategy and the company remained on the look out for small to mid-size acquisitions.
"We continue to look for bolt-on acquisitions that complement our platforms and products," Chief Executive Severin Schwan told a call for analysts on Tuesday.
SGEN ADCs mentioned again in Roche CC today. Roche will be presenting ph1 results at ASH if I understood correctly. SGEN at 30 pps by Dec.